Advocacy is one of the four core areas of focus of the International Myeloma Foundation. We are committed to improving the quality of life of myeloma patients, raising myeloma awareness, assisting those in the U.S. and abroad in navigating healthcare policies, and increasing access to multiple myeloma care and its treatments.
Subscribe to our advocacy e-mail list for the latest happenings and news.
Danielle Doheny joined IMF after a six-year career on Capitol Hill where she worked as an adviser to two members of Congress. As a Congressional staffer, Danielle’s primary focus was on healthcare and issues related to energy, the environment, science, and technology. In her role with the IMF, she advocates on behalf of the multiple myeloma community to the executive and legislative branches of the federal government. Danielle’s father is a multiple myeloma patient, and she has a unique passion for her work on behalf of patients and their families. Danielle graduated cum laude from Thiel College with a Bachelor of Arts degree in History.
Hello,
My name is Khyre Edwards; I am the new Manager of Grassroots Advocacy at the International Myeloma Foundation! I have worked in advocacy and organizing in some capacity for the last 20 years and am excited to bring those skills and experience here. I attended the University of South Florida and earned a dual bachelor’s degree in criminology and psychology. I previously worked with at risk youth as well as in local government providing healthcare and with nonprofits expanding programs and advocacy.
While I do not have a personal tie to Myeloma, I have had loved ones impacted by cancer and admire the great work everyone here has done to make life better for patients and their families.
In my free time I enjoy playing games with my children (Their current favorites are Munchkin, Cheating Monopoly, and Uno no mercy), gardening, and staying active. I am excited to join the team and hope to interact with you all soon!
Donating Stock to Charity
What Is Multiple Myeloma?
Myeloma is a cancer of the plasma cells in the bone marrow. The malignant plasma cells, or myeloma cells, accumulate in the bone marrow. These myeloma cells are abnormal plasma cells that divide uncontrollably, leading to the overproduction of dysfunctional antibodies and crowding out healthy blood cells.






